Cytokinetics (CYTK) Other Working Capital Changes (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Other Working Capital Changes of -$4.0 million for Q1 2026, down 343.92% year-over-year from $1.6 million in Q1 2025, and down 12.07% quarter-over-quarter from -$3.5 million in Q4 2025.
Cytokinetics (CYTK) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Other Working Capital Changes for 7 consecutive years, with -$4.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 343.92% year-over-year to -$4.0 million; the TTM figure through Mar 2026 stood at -$11.8 million (down 637.5% YoY), while the FY2025 annual figure was -$6.2 million, down 360.91% from the prior year.
- Other Working Capital Changes eased to -$4.0 million in Q1 2026 per CYTK's latest filing, from -$3.5 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $49.8 million in Q3 2025 and bottomed at -$51.0 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged -$1.2 million across 5 years, with a median of -$1.8 million in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 183.77% in 2025 and fell as far as 1729.41% in 2025.
- Cytokinetics' Other Working Capital Changes stood at -$203000.0 in 2022, then tumbled by 1661.58% to -$3.6 million in 2023, then surged by 106.63% to $237000.0 in 2024, then sank by 1588.61% to -$3.5 million in 2025, then declined by 12.07% to -$4.0 million in 2026.
- Business Quant data shows CYTK's Other Working Capital Changes at -$4.0 million in Q1 2026, -$3.5 million in Q4 2025, and -$2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.69 Mn |
| Jun 30, 2026 | -1.69 Mn |
| Jun 30, 2026 | -1.69 Mn |
| Mar 31, 2026 | -2.06 Mn |
| Mar 31, 2026 | -2.06 Mn |
| Mar 31, 2026 | -2.06 Mn |
| Dec 31, 2025 | -9.58 Mn |
| Dec 31, 2025 | -9.58 Mn |
| Dec 31, 2025 | -9.58 Mn |
| Sep 30, 2025 | 49.76 Mn |
| Sep 30, 2025 | 49.76 Mn |
| Sep 30, 2025 | 49.76 Mn |
| Jun 30, 2025 | -51.03 Mn |
| Jun 30, 2025 | -51.03 Mn |
| Jun 30, 2025 | -51.03 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Sep 30, 2024 | -1.82 Mn |
| Sep 30, 2024 | -1.82 Mn |